Generative artificial intelligence (AI), in the form of large language models (LLMs), has entered clinical practice faster than the evidence on how it changes clinical decisions could be produced. The relevant question is therefore no longer whether these models hold medical knowledge, but whether their use makes clini...
Chelsya Rafaela Brito Santiago, Christianni di Lorenzo, Adeagna Bento Laborda et al.· International Health Science...· 0 citations
Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce cardiovascular death and heart failure (HF) events across the whole spectrum of ejection fraction, and their benefit emerges within weeks of the first dose. This has moved the clinical question from whether to use them to when to start them. Hospitalization for a...
Chelsya Rafaela Brito Santiago, Cauan José Finato, Alaíze Nonato da Silva et al.· International Health Science...· 0 citations
The gut microbiota communicates with the central nervous system through neural, immune, endocrine and metabolic pathways collectively termed the microbiota-gut-brain axis. Because the microbiota can be modified by diet, probiotics, prebiotics and faecal microbiota transplantation (FMT), this axis has become a candidate...
Chelsya Rafaela Brito Santiago, Cecília Guedes de Freitas Rodrigues, Mariana Ferreira Barreiro et al.· International Health Science...· 0 citations
Oculomics leverages high-dimensional ocular imaging as a non-invasive window into systemic, microvascular, and central nervous system health. The integration of artificial intelligence (AI) and deep learning has revolutionized this field, expanding applications from localized ophthalmic diagnostics to systemic risk str...
Gabriela Barroso Sardinha, Letícia Jeronimo, I. D. da Silva et al.· International Health Science...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.